Search Results - "Daniel, Carnevali"
-
1
Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019
Published in The Journal of infectious diseases (12-08-2022)“…Abstract Use of interleukin (IL-6) inhibitors has become one of the most complicated clinical issues in treating coronavirus disease 2019 (COVID-19). Recently,…”
Get full text
Journal Article -
2
Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement
Published in International journal of cardiology. Heart & vasculature (01-10-2021)“…•Post-COVID-19 patients may incur myocardial involvement secondary to systemic inflammation. Compared to heathy controls, post-COVID-19 patients had raised T2…”
Get full text
Journal Article -
3
Cyclosporine A and COVID19 – The COQUIMA cohort – Author's reply
Published in EClinicalMedicine (01-01-2021)Get full text
Journal Article -
4
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
Published in The lancet respiratory medicine (01-12-2021)“…Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory properties. This study evaluates the efficacy and safety of…”
Get full text
Journal Article -
5
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
Published in Life science alliance (01-04-2022)“…Plitidepsin, a marine-derived cyclic-peptide, inhibits SARS-CoV-2 replication at nanomolar concentrations by targeting the host protein eukaryotic translation…”
Get full text
Journal Article -
6
COVID-19 and Metabolic Syndrome: NF-κB Activation. Crossroads
Published in Trends in endocrinology and metabolism (01-11-2020)Get full text
Journal Article -
7
Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment
Published in Infectious diseases (London, England) (02-07-2024)“…To study the effect of plitidepsin antiviral treatment in immunocompromised COVID-19 patients with underlying haematological malignancies or solid tumours,…”
Get full text
Journal Article -
8
Oral Ganciclovir as Prophylaxis against Cytomegalovirus
Published in The New England journal of medicine (31-10-1996)“…To the Editor: Spector et al. (June 6 issue) 1 conclude that oral ganciclovir “promises to be a useful drug for prophylaxis against CMV [cytomegalovirus]…”
Get full text
Journal Article -
9
What is the relevance of anemia treatment among the novel therapies of heart failure?
Published in Medicina clínica (07-02-2004)Get more information
Journal Article -
10